透過您的圖書館登入
IP:3.144.248.24
  • 期刊

節拍式化療來治療復發的卵巢上皮癌

Metronomic Chemotherapy in the Management of Recurrent Epithelial Ovarian Cancer

摘要


卵巢上皮癌,一旦復發,預後均很差,超過五年的存活率幾乎不可能。在早期的治療方式,如果可以再開刀,均選擇在將其內的腫瘤儘可能的切除,在選擇第一線或第二線的抗癌藥物治療。當然也有捨棄手術,直接進行化療的做法。但是如同上述,不管採取何種方法,這類病人預後顯然都不好,一般都已三年存活率來評估,超過五年的存活率幾乎不可能。因為有「節拍式的治療」的概念,需我們將這樣的想法用在病患的治療身上。本病例,就是介紹一位復發的卵巢上皮癌。患者,從復發的第二次手術,經過節拍式的化療,已經存活超過十年。

並列摘要


The prognosis of recurrent epithelial ovarian cancer is extremely poor. It is impossible to live more than 5 years when women had recurrent epithelial ovarian cancers. provide little chance to survive. We used the "metronomic therapy" strategy in the effectively prolonged the survival of a patient with recurrent epithelial ovarian cancer. After Chemotherapy is a main therapy, regardless of recurrence, this patient had a more than 10-year repeat surgery status. However, both strategies survival.

延伸閱讀